Only a fraction of side effects associated with the obesity drug orlistat, sold as the prescription drug Xenical and the over-the-counter medicine Alli, were published in papers and summarized clinical study reports submitted to the European Medicines Agency (EMA), according to a study conducted by researchers with the Nordic Cochrane Centre in Copenhagen. The study used the Freedom of Information Act to acquire clinical study reports from the EMA that included seven randomized placebo-controlled trials of orlistat involving 4,225 patients. The data was reviewed by drug regulators in both the U.K. and the U.S., who voted to approve Xenical in ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.